BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38325291)

  • 1. TRANSCRIPTOME ANALYSIS REVEALED THE MOLECULAR SIGNATURES OF CISPLATIN-FLUOROURACIL COMBINED CHEMOTHERAPY RESISTANCE IN GASTRIC CANCER.
    Luo Y; Chen X; Hu E; Wang L; Yang Y; Jiang X; Zheng K; Wang L; Li J; Xu Y; Wang Y; Xie Y
    Georgian Med News; 2023 Dec; (345):6-18. PubMed ID: 38325291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five hub genes contributing to the oncogenesis and trastuzumab-resistance in gastric cancer.
    Chen F; Wang Y; Zhang X; Fang J
    Gene; 2023 Jan; 851():146942. PubMed ID: 36202277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
    Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
    PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Gastric Carcinoma using Bioinformatics Analysis.
    Yang G; Zhang Y; Yang J
    Med Sci Monit; 2019 Nov; 25():8777-8796. PubMed ID: 31747387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
    Li D; Yin Y; He M; Wang J
    Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer.
    Yang G; Jian L; Lin X; Zhu A; Wen G
    Dis Markers; 2019; 2019():1372571. PubMed ID: 31949544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemo-resistant Gastric Cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus.
    Liu JB; Jian T; Yue C; Chen D; Chen W; Bao TT; Liu HX; Cao Y; Li WB; Yang Z; Hoffman RM; Yu C
    Anticancer Res; 2019 Apr; 39(4):1689-1698. PubMed ID: 30952707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of gene signatures and potential therapeutic targets for acquired chemotherapy resistance in gastric cancer patients.
    Sun J; Zhao J; Yang Z; Zhou Z; Lu P
    J Gastrointest Oncol; 2021 Apr; 12(2):407-422. PubMed ID: 34012635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.
    Liu J; Cheng Z
    Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-182 is a potential biomarker for prognosis of gastric cancer: A protocol for meta-analysis and bioinformatics analysis.
    Xiao D; Xie J; Wu S
    Medicine (Baltimore); 2021 Jun; 100(22):e25830. PubMed ID: 34087825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of survival-associated biomarkers based on three datasets by bioinformatics analysis in gastric cancer.
    Yin LK; Yuan HY; Liu JJ; Xu XL; Wang W; Bai XY; Wang P
    World J Clin Cases; 2023 Jul; 11(20):4763-4787. PubMed ID: 37584004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 13. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.
    Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y
    Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Elucidation of the Mechanism of Quercetin against Gastric Cancer via Network Pharmacology Approach.
    Yang L; Hu Z; Zhu J; Liang Q; Zhou H; Li J; Fan X; Zhao Z; Pan H; Fei B
    Biomed Res Int; 2020; 2020():3860213. PubMed ID: 32964029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hub genes and pathways in gastric cancer: A comparison between studies that used normal tissues adjacent to the tumour and studies that used healthy tissues as calibrator.
    Sadegh K; Ahmadi A
    IET Syst Biol; 2023 Jun; 17(3):131-141. PubMed ID: 37118990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Matrix-Related Hubs Genes Have Adverse Effects on Gastric Adenocarcinoma Prognosis Based on Bioinformatics Analysis.
    Alatan H; Chen Y; Zhou J; Wang L
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of a circRNA-miRNA-mRNA Network to Reveal Potential Inflammation-Related Targets for Gastric Adenocarcinoma.
    Liu Y; Xu Y; Xiao F; Zhang J; Wang Y; Yao Y; Yang J
    Mediators Inflamm; 2020; 2020():9435608. PubMed ID: 32801999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
    Yang J
    Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
    Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
    Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.